Equity-Based Compensation |
6 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | ||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||
| Equity-Based Compensation | 4. Equity-Based Compensation We granted 29,383 and 8,984 restricted stock units (RSUs) during the three months ended June 30, 2026 and 2025, respectively, and granted 837,553 and 495,334 RSUs during the six months ended June 30, 2026 and 2025, respectively. Equity-based compensation expense related to RSUs was $29.4 million and $24.3 million during the three months ended June 30, 2026 and 2025, respectively, and $55.9 million and $53.1 million during the six months ended June 30, 2026 and 2025, respectively. We present below a summary of changes during the six months ended June 30, 2026 in our unvested restricted stock units:
|
|||||||||||||||||||||||||||||||||||